Burning Rock Biotech Limited Gains 35.96%
Mon, Aug 18, 2025 at 07:43 PM
Burning Rock Biotech Limited (BNR:NASDAQ) rocketted at $10.17, representing a gain of 36%. On Mon, Aug 18, 2025, BNR:NASDAQ hit a New 2-Week High of $10.17. The stock appeared on our News Catalysts scanner on Sun, Aug 03, 2025 at 09:06 PM in the 'INVESTOR UPDATE' category. From Mon, Aug 04, 2025, the stock recorded 80.00% Up Days and 54.55% Green Days
About Burning Rock Biotech Limited (BNR:NASDAQ)
Burning Rock Biotech Ltd is a cancer diagnostics company. Its products include OncoScreen Plus and ColonCore.
Top 10 Gainers:
- Hempacco Co., Inc. (HPCO:NASDAQ), 350%
- Soligenix, Inc. (SNGX:NASDAQ), 78.42%
- Aspire Biopharma Holdings, Inc. (ASBP:NASDAQ), 64.35%
- Catheter Precision, Inc. (VTAK:NYSEMKT), 62.84%
- ALX Oncology Holdings Inc. (ALXO:NASDAQ), 50.69%
- Xunlei Limited (XNET:NASDAQ), 37.56%
- GoodRx Holdings, Inc. (GDRX:NASDAQ), 37.27%
- Burning Rock Biotech Limited (BNR:NASDAQ), 35.96%
- ImmunoPrecise Antibodies Ltd. (IPA:NASDAQ), 35%
- Iron Horse Acquisitions Corp. (IROH:NASDAQ), 29.86%